Evaluation and Management of Alcohol use Disorder among Older Adults.
Evaluation and Management of Alcohol use Disorder among Older Adults.
复制标题
DOI：
10.1007/s13670-021-00359-5
复制
发表时间：
2021
影响因子：
1.2
通讯作者：
Wilkins KM
中科院分区：
文献类型：
--
作者：
Joshi P;Duong KT;Trevisan LA;Wilkins KM
美国老年人酒精使用障碍（AUD）的患病率正在上升，但仍然诊断不足，报告不足，管理不当。这篇综述强调了老年人AUD的医学，社会和文化因素，并为其筛查，评估和管理提供了指南。2019冠状病毒病大流行为护理带来了额外的挑战和障碍，因为老年人可能会因与物理距离和就地庇护指南相关的隔离增加而导致焦虑、抑郁和物质使用不成比例地恶化。所有老年人都应使用标准化筛查工具进行AUD常规筛查。如果患者的筛查结果呈阳性，临床医生应进行简要评估，并可通过实验室检查进行补充。大多数有酒精滥用风险的老年人不需要专门的SUD治疗，但大多数人可以从筛查，短暂干预和转诊治疗（SBIRT）中受益，以防止药物滥用。治疗老年人AUD的药物包括纳洛酮、阿坎酸、双硫仑、加巴喷丁和托吡酯。心理治疗，包括互助小组，也同样重要。
The prevalence of alcohol use disorder (AUD) among older adults in the United States is rising, but remains underdiagnosed, underreported, and inadequately managed. This review highlights the medical, social, and cultural factors of AUD in older adults and provides guidelines for its screening, evaluation, and management. The COVID-19 pandemic has created additional challenges and barriers to care, as older adults may have disproportionate worsening of anxiety, depression, and substance use resulting from increased isolation related to physical distancing and shelter-in-place guidelines. All older adults should be routinely screened for AUD with standardized screening tools. If a patient’s screening results are positive, a clinician should conduct a brief assessment, which may be supplemented by laboratory tests. Most older adults at risk for alcohol misuse do not need specialized SUD treatment, but most can benefit from Screening, Brief Intervention, and Referral to Treatment (SBIRT) to prevent substance misuse before it occurs. Medications for the treatment of AUD in older adults include naltrexone, acamprosate, disulfiram, gabapentin and topiramate. Psychosocial treatments, including mutual help groups, are equally important.
登录
查看更多内容
影响因子：
39
作者：
Mason, Barbara J.;Quello, Susan;Begovic, Adnan
通讯作者：
Begovic, Adnan
影响因子：
25.8
作者：
Grant BF;Goldstein RB;Saha TD;Chou SP;Jung J;Zhang H;Pickering RP;Ruan WJ;Smith SM;Huang B;Hasin DS
通讯作者：
Hasin DS
影响因子：
--
作者：
Bush, K;Kivlahan, DR;Bradley, KA
通讯作者：
Bradley, KA
影响因子：
3.7
作者：
Friedrichs A;Spies M;Härter M;Buchholz A
通讯作者：
Buchholz A
DOI：
10.4137/sart.s7865
发表时间：
2013
期刊：
Substance abuse : research and treatment
影响因子：
--
作者：
Kuerbis A;Sacco P
通讯作者：
Sacco P